Stopping eye injections for wet macular degeneration carries a real risk of the disease reactivating and vision declining, sometimes permanently. In one study tracking patients after treatment was suspended, about 74% experienced a recurrence of the disease within five years, with half of those recurrences happening in the first year alone. The outcome depends heavily on why you stopped, how long the gap lasts, and how your eye responded to treatment before stopping.
Why the Disease Comes Back
Wet macular degeneration is driven by abnormal blood vessels that grow beneath the retina and leak fluid. The injections you receive work by blocking the protein that fuels that blood vessel growth. They don’t cure the underlying condition. They suppress it. When the medication wears off and isn’t replaced with another dose, those abnormal vessels can start leaking again, and new ones can form.
The median time for recurrence after stopping treatment is about 12 months, but it varies widely. Roughly half of recurrences happen within the first year. Others show up two, three, or even four years later. A small percentage of patients, about 26%, showed no recurrence within five years of stopping, which means some eyes do remain stable. But there’s no reliable way to predict in advance whether yours will be one of them.
How Much Vision You Could Lose
The amount of vision loss depends on the reason treatment stopped. Patients who discontinued because their disease was already responding poorly (with scarring or atrophy in the macula) lost a median of 17 letters on the eye chart, roughly three to four lines. That’s a significant drop, potentially the difference between reading a book and not being able to make out faces across a room.
A landmark study called SEVEN-UP followed patients for an average of 7.3 years after they first started treatment. By that point, one-third had good vision (20/70 or better), but another third had vision of 20/200 or worse, which meets the threshold for legal blindness. Thirty-four percent had lost 15 or more letters compared to when they started. Notably, patients who continued receiving more injections during the follow-up period had significantly better outcomes than those who received fewer.
Active leaking disease was still detectable in 68% of eyes at that late stage, and nearly all eyes (98%) showed some degree of macular atrophy. The area of atrophy was strongly linked to worse vision. This tells a sobering story: wet macular degeneration remains a threat for years, and undertreating it has cumulative consequences.
Can You Recover Lost Vision by Restarting?
This is the question most people really want answered, and the news is not encouraging. Research examining patients who took a break from injections and then resumed treatment found that vision loss during the gap was mostly irreversible. In one study of patients with macular degeneration who paused and restarted, only three eyes recovered to their pre-gap level of vision. Some improvement occurred after resuming injections, meaning the fluid and swelling could be reduced again, but the visual acuity that was lost during the interruption largely stayed lost.
The likely explanation is that when fluid and blood leak beneath the retina unchecked, they damage the delicate photoreceptor cells that can’t regenerate. A gap longer than six months is considered particularly risky. Research suggests that interruptions beyond that threshold can lead to permanent vision loss even when treatment resumes.
When Doctors Recommend Stopping
Not all treatment stops are harmful. In real-world practice, about 28% of patients discontinue injections, and the most common reason is a clinical decision by the treating doctor. Among those clinical decisions, roughly 53% were made because the eye showed no signs of active leaking after a period of treatment. These patients had the best vision at the time of stopping, with significantly better scores on eye charts compared to those who stopped for other reasons.
Doctors also recommend stopping when further treatment is considered futile, typically because the macula has already developed permanent scarring or extensive atrophy. In these cases, the injections are no longer providing meaningful benefit. About 100 out of 1,177 patients in one large study fell into this category.
The approach most doctors use today isn’t an abrupt stop. It’s a gradual extension of the time between injections, sometimes called treat-and-extend. Your doctor stretches the interval from, say, four weeks to six, then eight, then twelve, monitoring for any return of fluid at each visit. If the eye stays dry at longer intervals, some patients can eventually be observed without active injections, though monitoring continues.
Why People Stop on Their Own
Nearly half of patients in long-term studies fail to complete five years of follow-up, and the reasons go well beyond the disease itself. Death accounts for a large share, particularly since macular degeneration primarily affects older adults. But other factors include declining overall health, difficulty getting to appointments, and simple fatigue with the process. In one cohort, 68 patients chose to stop against their doctor’s advice due to poor motivation or the burden of other health conditions.
The treatment burden is real. Injections typically happen every four to eight weeks, each visit requiring transportation, waiting, the procedure itself, and recovery time. For someone in their 80s managing multiple health problems, that schedule can feel unsustainable. But the data consistently shows that eyes receiving more injections over time do better than eyes receiving fewer, so each skipped or delayed appointment carries a cost that accumulates.
What Monitoring Looks Like After Stopping
If your doctor agrees that stopping is reasonable because your eye has been stable, you’ll still need regular monitoring. Recurrence can happen years later, and catching it early gives the best chance of limiting damage. Typical monitoring involves optical coherence tomography (OCT) scans, which create a cross-section image of your retina and can detect tiny amounts of fluid before you notice any vision change.
Between appointments, you can monitor yourself at home with an Amsler grid, a simple pattern of straight lines. If the lines start appearing wavy, distorted, or missing in spots, that’s a sign fluid may be accumulating again and you should contact your eye doctor promptly. The speed of restarting treatment after a recurrence matters. The sooner leaking is suppressed again, the less permanent damage occurs.
The Bottom Line on Treatment Gaps
Short, planned extensions in the time between injections under a doctor’s supervision are a normal part of modern treatment. Abruptly stopping on your own is a different situation entirely. The disease recurs in the majority of eyes within a few years, vision loss during a treatment gap is largely permanent, and restarting injections after a long break typically cannot undo the damage. If the treatment burden feels overwhelming, the most productive conversation to have with your retina specialist is about extending intervals or switching medications rather than stopping altogether.